BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37263180)

  • 1. China lung cancer screening (CLUS) version 2.0 with new techniques implemented: Artificial intelligence, circulating molecular biomarkers and autofluorescence bronchoscopy.
    Zhang Y; Qian F; Teng J; Wang H; Yu H; Chen Q; Wang L; Zhu J; Yu Y; Yuan J; Cai W; Xu N; Zhu H; Lu Y; Yao M; Zhu J; Dong J; Yu L; Ren H; Yang J; Sun J; Zhong H; Han B
    Lung Cancer; 2023 Jul; 181():107262. PubMed ID: 37263180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [China National Lung Cancer Screening Guideline with Low-dose Computed Tomography (2023 Version)].
    ;
    Zhongguo Fei Ai Za Zhi; 2023 Jan; 26(1):1-9. PubMed ID: 36792074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Risk factors for lung cancer based on low-dose computed tomography screening].
    Jin YJ; Tang W; Huang Y; Wang JW; Hou DH; Qi LL; Zhao SJ; Wu N
    Zhonghua Zhong Liu Za Zhi; 2020 Mar; 42(3):222-227. PubMed ID: 32252201
    [No Abstract]   [Full Text] [Related]  

  • 4. Integration of multiple "OMIC" biomarkers: A precision medicine strategy for lung cancer.
    Robles AI; Harris CC
    Lung Cancer; 2017 May; 107():50-58. PubMed ID: 27344275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Results of low-dose computed tomography (LDCT) screening for early lung cancer: prevalence in 4 690 asymptomatic participants].
    Tang W; Wu N; Huang Y; Wang J; Zhao S; Xu Z; Zhang K; Jiang Y; Cai Q; Zhou L; Li M; Tao D; Liu X; Wang Y
    Zhonghua Zhong Liu Za Zhi; 2014 Jul; 36(7):549-54. PubMed ID: 25327664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-off low-dose CT for lung cancer screening in China: a multicentre, population-based, prospective cohort study.
    Li N; Tan F; Chen W; Dai M; Wang F; Shen S; Tang W; Li J; Yu Y; Cao W; Xu Y; Qin C; Zhao L; Zhu M; Guo L; Wu Z; Yang Z; Zheng Y; Chen H; Liu Y; Wei D; Dong D; Cao J; Zhang S; Yan S; Wang N; Du L; Shen H; Wu N; He J;
    Lancet Respir Med; 2022 Apr; 10(4):378-391. PubMed ID: 35276087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effectiveness Evaluation of Low-dose Spiral Computed Tomography 
for Lung Cancer Screening in Minhang District of Shanghai].
    Teng J; Yao W; Li W; Cheng Y; Li J; Xu H; Xu W
    Zhongguo Fei Ai Za Zhi; 2024 Jan; 27(1):13-24. PubMed ID: 38296622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential screening for lung cancer in a high-risk group: randomised controlled trial: LungSEARCH: a randomised controlled trial of Surveillance using sputum and imaging for the EARly detection of lung Cancer in a High-risk group.
    Spiro SG; Shah PL; Rintoul RC; George J; Janes S; Callister M; Novelli M; Shaw P; Kocjan G; Griffiths C; Falzon M; Booton R; Magee N; Peake M; Dhillon P; Sridharan K; Nicholson AG; Padley S; Taylor MN; Ahmed A; Allen J; Ngai Y; Chinyanganya N; Ashford-Turner V; Lewis S; Oukrif D; Rabbitts P; Counsell N; Hackshaw A
    Eur Respir J; 2019 Oct; 54(4):. PubMed ID: 31537697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung Cancer Screening with Low-Dose CT: Baseline Screening Results in Shanghai.
    Fan L; Wang Y; Zhou Y; Li Q; Yang W; Wang S; Shan F; Zhang X; Shi J; Chen W; Liu SY
    Acad Radiol; 2019 Oct; 26(10):1283-1291. PubMed ID: 30554839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose computed tomography lung cancer screening: Clinical evidence and implementation research.
    Lancaster HL; Heuvelmans MA; Oudkerk M
    J Intern Med; 2022 Jul; 292(1):68-80. PubMed ID: 35253286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic work-up and surgery in participants of the Gdansk lung cancer screening programme: the incidence of surgery for non-malignant conditions.
    Rzyman W; Jelitto-Gorska M; Dziedzic R; Biadacz I; Ksiazek J; Chwirot P; Marjanski T
    Interact Cardiovasc Thorac Surg; 2013 Dec; 17(6):969-73. PubMed ID: 24008181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Community-based lung cancer screening with low-dose CT in China: Results of the baseline screening.
    Yang W; Qian F; Teng J; Wang H; Manegold C; Pilz LR; Voigt W; Zhang Y; Ye J; Chen Q; Han B;
    Lung Cancer; 2018 Mar; 117():20-26. PubMed ID: 29496251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Necessity of organized low-dose computed tomography screening for lung cancer: From epidemiologic comparisons between China and the Western nations.
    Gou HF; Liu Y; Yang TX; Zhou C; Chen XZ
    Oncotarget; 2017 Jan; 8(1):1788-1795. PubMed ID: 27705946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The promises and challenges of early non-small cell lung cancer detection: patient perceptions, low-dose CT screening, bronchoscopy and biomarkers.
    Kalinke L; Thakrar R; Janes SM
    Mol Oncol; 2021 Oct; 15(10):2544-2564. PubMed ID: 33252175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating Tumor-Macrophage Fusion Cells and Circulating Tumor Cells Complement Non-Small-Cell Lung Cancer Screening in Patients With Suspicious Lung-RADS 4 Nodules.
    Manjunath Y; Suvilesh KN; Mitchem JB; Avella Patino DM; Kimchi ET; Staveley-O'Carroll KF; Pantel K; Yi H; Li G; Harris PK; Chaudhuri AA; Kaifi JT
    JCO Precis Oncol; 2022 Mar; 6():e2100378. PubMed ID: 35417204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screening.
    Sestini S; Boeri M; Marchiano A; Pelosi G; Galeone C; Verri C; Suatoni P; Sverzellati N; La Vecchia C; Sozzi G; Pastorino U
    Oncotarget; 2015 Oct; 6(32):32868-77. PubMed ID: 26451608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung cancer screening using low-dose computed tomography in at-risk individuals: the Toronto experience.
    Menezes RJ; Roberts HC; Paul NS; McGregor M; Chung TB; Patsios D; Weisbrod G; Herman S; Pereira A; McGregor A; Dong Z; Sitartchouk I; Boerner S; Tsao MS; Keshavjee S; Shepherd FA
    Lung Cancer; 2010 Feb; 67(2):177-83. PubMed ID: 19427055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening baseline characteristics of early lung cancer on low-dose computed tomography with computer-aided detection in a Chinese population.
    Liu Y; Luo H; Qing H; Wang X; Ren J; Xu G; Hu S; He C; Zhou P
    Cancer Epidemiol; 2019 Oct; 62():101567. PubMed ID: 31326849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low Prevalence of High-Grade Lesions Detected With Autofluorescence Bronchoscopy in the Setting of Lung Cancer Screening in the Pan-Canadian Lung Cancer Screening Study.
    Tremblay A; Taghizadeh N; McWilliams AM; MacEachern P; Stather DR; Soghrati K; Puksa S; Goffin JR; Yasufuku K; Amjadi K; Nicholas G; Martel S; Laberge F; Johnston M; Shepherd FA; Ionescu DN; Urbanski S; Hwang D; Cutz JC; Sekhon HS; Couture C; Xu Z; Sutedja TG; Atkar-Khattra S; Tammemagi MC; Tsao MS; Lam SC;
    Chest; 2016 Nov; 150(5):1015-1022. PubMed ID: 27142184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of lung cancer screening with low-dose CT in Gejiu, Yunnan: A population-based, screening cohort study.
    Wei MN; Su Z; Wang JN; Gonzalez Mendez MJ; Yu XY; Liang H; Zhou QH; Fan YG; Qiao YL
    Thorac Cancer; 2020 May; 11(5):1224-1232. PubMed ID: 32196998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.